AMETEK acquires Paragon Medical

AMETEK acquired Paragon Medical for approximately $1.9 billion, a transaction completed in December 2023, structured as all cash.

Paragon Medical operates in EMG, had revenue of about approximately $500 million in annual sales. A leading provider of highly engineered medical components and instruments, acquired from affiliates of American Securities LLC. Paragon serves orthopedics, minimally invasive surgery, robotic surgery, and drug delivery, with a portfolio of single-use and consumable surgical instruments and implantable components sold to a blue-chip base of leading medical device manufacturers.

Paragon's outstanding capabilities and market leadership align seamlessly with AMETEK's commitment to delivering high-performance solutions, further broadening AMETEK's presence in the attractive MedTech industry.

Market leadership in highly engineered medical components, blue-chip medtech customer base, exposure to attractive MedTech end markets. Broadens AMETEK's presence in the MedTech industry within EMG. Electromechanical Group (EMG) We incurred costs in the first quarter for integration costs related to the Paragon Medical acquisition. (AMETEK earnings call, Q4 2025)

Advisory firms were not disclosed for this transaction.